Navigation Links
Mirixa Corporation Announces MirixaEdge(SM)
Date:10/19/2009

NEW ORLEANS, Oct. 19 /PRNewswire/ -- NCPA 111th Annual Convention -- Mirixa Corporation, the leader in targeted pharmacy-based patient care services, has announced the launch of MirixaEdge(SM). Previewed to independent pharmacists at the National Community Pharmacists Association's annual convention, MirixaEdge enables pharmacists to design their own patient care programs for any of their patients regardless of health plan, employer, or age.

MirixaEdge capitalizes on the nation's leading web-based clinical platform, MirixaPro(SM), which is available to over 40,000 contracted pharmacies nationwide to identify patient health care issues, highlight potential medication-related interactions, and encourage standardized care by pharmacists. MirixaEdge helps jumpstart the process of personalized program creation by providing pharmacists with pre-defined templates for conditions such as diabetes, asthma, and cardiovascular disease. Pharmacists can also take advantage of a template for medication therapy management. Additional MirixaEdge templates are planned.

"MirixaEdge helps pharmacists improve health outcomes for their patients, drive down health care costs and provide greater access to care," said Rick Solano, Mirixa's Chief Executive Officer. "The product expands patient care opportunities for community pharmacy and enables pharmacists to proactively engage their patients in the kind of dialogue that drives customer loyalty and trust."

MirixaEdge provides pharmacies with a standardized platform on which to establish their unique pharmacy patient care programs, capture outcomes measurements, and use that information to educate patients about their health issues.

A select group of MirixaPro participating pharmacies have participated in beta testing of MirixaEdge. One member of the pilot group, Justin Wilson, PharmD., of Valu-Med Pharmacy in Midwest City, OK, anticipates that using MirixaEdge will enhance customer relations and notes, "This tool will provide our pharmacy with a mechanism to proactively engage patients in a dialogue about their medication. By initiating a discussion, our pharmacists will be better able to advise and educate the patient while at the same time encouraging them to adhere to their medication regime and to focus on healthy lifestyle choices."

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

    Contact:     Anne Marie Heil
                 610-933-8065 (o)
                 484-886-7540 (c)
                 amheil@amheil.com

SOURCE Mirixa Corporation


'/>"/>
SOURCE Mirixa Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Mirixa Corporation Announces Key Pharmacy Network Hire
2. WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders
3. Baxa Corporation Signs Exclusive Distribution Agreement With Leading Pharmaceutical Corporation in Peoples Republic of China
4. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
5. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
6. CEL-SCI Corporation Releases Letter to Shareholders
7. ETEX Corporation Announces Additional FDA Clearance For EquivaBone(R), The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substitute.
8. Clinical Logistics Enters Partnership with Gentris Corporation
9. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
10. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
11. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017  Akcea Therapeutics, a subsidiary ... to the company,s board of directors: ... Partners. Mr. Gabrieli will serve as chairman of the board ... former chief commercial officer of Forest Laboratories. ... Biolink Partners. "We are excited to ...
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... is expected to reach USD 8.0 billion by 2025, ... Inc. The increasing incidence of infectious diseases and cancer ... for use in disease diagnosis over the coming years. ... the usage of autologous and allogenic stem cell therapy, ...
(Date:3/27/2017)... LONDON , March 27, 2017 ... require to better understand Eli Lilly and its partnering interests ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ... deal and company data. The report will be ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... Paul Yost, will begin serving as new board chair for Orange County health ... will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which runs ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric ... Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System to his ... to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu ...
(Date:3/28/2017)... Albertson, NY (PRWEB) , ... March 28, 2017 , ... Oily skin is a common ... with Advanced Dermatology has a lot to offer to the discussion of dealing ... good news is that there are many home remedies that can help remove the oily ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... with or without a referral. Sleep apnea is often left untreated because patients are ... headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep ...
Breaking Medicine News(10 mins):